Pharmaceutical manufacturers are utilizing new RIFD technologies to deal with multiple challenges they face in the manufacturing process. This Kalorama Information report discussions the solutions available, and covers the opportunities available to technology companies to provide services to this sector.
Full coverage of the market for RFID technologies in pharmaceutical manufacturing operations is provided, including.
- Explanation of RFID Technologies
- Cost Savings from Implementation
- Total Market for RFID Technologies in Pharma Manufacturing
- Market Forecasts
- Major Companies Involved in RFID and its use in Pharma
In order to efficiently cope with the changing structure of the industry, pharmaceutical companies and distributors are working to find suitable technologies to maintain patient safety and to streamline business. There are a number of solutions to help in this effort but radiofrequency identification (RFID) is positioned to be a top solution in manufacturing and distribution, clinical trials, and sample distribution.
Due to the nature of the manufacturing and distribution of pharmaceutical products, the scope of the study includes these two interconnected segments. This report describes RFID potential and opportunities in the US, outlines key market trends and dynamics, and analyzes the value chain and customer preferences.
As part of Kalorama Information’s trusted information-gathering process, research is conducted but the report is the result of primary research — interviews with experts provide the basis for the findings of this market study.
The following corporations are profiled in this report.
- Alien Technology
- Blue Vector
- International Business Machines (IBM) Corporation
- Intermec, Inc.
- Motorola, Inc.
- Tagsys, Inc.
- Toshiba TEC
- Zebra Technologies Corporation
License Note: Kalorama Information’s listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.